It's apparently a monoclonal antibody (https://en.wikipedia.org/wiki/Bimekizumab). That's just a protein, so it might actually be easier to make in your garage than your average small molecule ;) ... not that either would be practically possible, but it might be available in countries where they don't care too much about patents and such